Home›Stock Screener›Makers Laboratories

Makers Laboratories Share Price Today | Stock Price & Makers Laboratories Share Screener

MAKERSL Pharmaceuticals
Live Share Price NSE
₹177.40
▼ -6.10 (-3.32%)
2026-10-05 00:00:00
Live Share Price BSE
₹180.35
▼ -1.35 (-0.74%)
2026-10-05 00:00:00

As of October 5, 2026, the live Makers Laboratories share price (NSE: MAKERSL) is ₹177.40 on NSE and ₹180.35 on BSE, down 3.32% from the previous close, with shares trading between ₹175.00 and ₹187.49 in today's trading session, and a 52-week range of ₹152.59–₹220.86. Check MAKERSL price range for the annual price range and momentum. Use the Makers Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Makers Laboratories opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹37 and net income of ₹4, with EBITDA of ₹6, an operating margin of 15.0% and a profit margin of 10.8%.

Makers Laboratories Market Cap ₹108.27 Cr.
MAKERSL P/E Ratio (TTM) 9.80
Makers Laboratories P/B Ratio 1.50
EPS (TTM) ₹3.99
Dividend Yield -
Debt to Equity 0.12
MAKERSL 52 Week High ₹220.86
Makers Laboratories 52 Week Low ₹152.59
Operating Margin 15.00%
Profit Margin 10.81%
MAKERSL Revenue (TTM) ₹37.00
EBITDA ₹6.00
Net Income ₹4.00
Total Assets ₹167.00
Total Equity ₹123.00

Makers Laboratories Share Price Chart

Track the current stock price of Makers Laboratories with an interactive chart. Analyse MAKERSL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Makers Laboratories stock quote in one place.

The quote of ₹177.40 sits between the 52-week low of ₹152.59 and the 52-week high of ₹220.86, and the latest session moved -3.32% from the previous close.

Makers Laboratories Company Profile - Fundamental Screener

Screen Makers Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MAKERSL shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE987A01010.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE987A01010

Makers Laboratories Balance Sheet Screener

Screen MAKERSL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹167, up from ₹148 in 2025.

Latest statistics put total assets at ₹167 and shareholder funds at ₹123, with a leverage ratio of 0.12.

Item 2026 2025 2024 2023 2022 2021

Assets

Total Assets 167 148 161 152 144 136
Current Assets 87 68 70 63 63 61
Fixed Assets 71 74 87 85 68 71

Liabilities

Total Liabilities 0 0 0 0 0 0
Current Liabilities 10 12 20 15 13 17
Non-Current Liabilities 0 0 0 0 0 0

Shareholders' Equity

Total Equity 123 115 104 110 98 87
Share Capital 6 6 6 6 5 5
Reserves & Surplus 67 65 57 63 55 49

Makers Laboratories Income Statement Screener - Profit & Revenue Analysis

Screen Makers Laboratories income statement and profit fundamentals. Analyze MAKERSL quarterly results. Makers Laboratories reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹37 and net profit was ₹4, equal to earnings per unit of ₹1.85, at an operating margin of 15%.

In that period expenses were ₹31, interest cost ₹0 and tax ₹1. The next period listed, 2026-Jun, shows revenue of ₹43 and net profit of ₹5.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar

Revenue and Expenses

Revenue 37 43 34 35 35 36 28 30 40 29 30 25 26 27 28
Expenses 31 36 31 32 32 32 27 29 27 26 28 25 25 26 25

Operating Costs and Margins

EBITDA 6 8 3 3 3 5 1 1 13 2 2 0 1 1 3
Operating Profit % 15.00% 16.00% 9.00% 9.00% 7.00% 12.00% 3.00% 3.00% 7.00% 5.00% 6.00% -1.00% 1.00% 1.00% 7.00%
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Interest 0 0 0 0 0 0 1 1 0 0 0 0 1 1 0

Profit and Earnings

Profit Before Tax 5 6 2 2 1 3 0 -1 11 1 1 -1 -1 -1 1
Tax 1 2 1 1 1 1 1 0 1 0 0 0 0 0 0
Net Profit 4 5 2 1 1 2 -1 -1 10 0 0 -2 -1 -1 1
EPS 1.85 2.55 -0.08 0.74 -0.20 1.59 -2.18 -1.67 14.94 -0.50 -0.43 -3.55 -2.27 -2.61 -1.24

Makers Laboratories Cash Flow Screener - Liquidity Fundamentals

Screen MAKERSL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹14.

Over the same period, investing activities used ₹15 and financing activities provided ₹0.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March

Cash from Operations and Investing

Operating Activities 14 -4 1 -9 19 0
Investing Activities -15 20 -7 1 -22 0

Financing and Net Cash

Financing Activities 0 -16 6 6 0 0
Net Cash Flow 0 0 0 -2 -3 0

Makers Laboratories Shareholding Pattern Screener

See Makers Laboratories shareholding pattern with promoter, FII, and DII holdings. Check Makers Laboratories promoter holding and ownership changes for MAKERSL on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 61.27%, foreign institutions 0.00%, domestic institutions 0.39% and the public 31.72%, spread across 3,745 shareholders.

The shareholder count was 3,745 in 2026-Jun, compared with 3,801 in 2026-Mar.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept

Promoter Holding

Promoter Holding 61.27% 61.27% 61.27% 61.27% 61.27% 61.27% 61.27% 61.27%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.39% 0.39% 0.39% 0.39% 0.39% 0.39% 0.39% 0.39%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 31.72% 31.47% 31.20% 30.98% 31.01% 30.90% 30.67% 30.86%
Other Holding 6.62% 6.86% 7.14% 7.36% 7.33% 7.43% 7.67% 7.48%
Shareholder Count 3,745 3,801 3,926 4,026 4,073 4,135 4,031 4,008

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Makers Laboratories. Makers Laboratories dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹1.00 3.50%
2018-March ₹1.00 1.98%
2017-March ₹1.00 1.42%

Makers Laboratories Stock Index Membership - Nifty & Sensex

See which indices include Makers Laboratories stock. Check MAKERSL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Makers Laboratories is not part of any tracked indices.
Only major market indices are tracked in our system.

Makers Laboratories Market Events Screener - Corporate Actions

Get Makers Laboratories corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Makers Laboratories stock events that may affect MAKERSL share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated August 7, 2026, with a record date of August 7, 2026.

It is followed by Annual General Meeting dated August 7, 2026 and Quarterly Result Announcement dated May 26, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-08-07 2026-08-07 Quarterly Result Announcement NA 9.54%
2026-08-07 2026-08-07 Annual General Meeting NA 7.66%
2026-05-26 2026-05-26 Quarterly Result Announcement NA 9.65%
2026-02-10 2026-02-10 Quarterly Result Announcement NA 12.28%
2025-11-07 2025-11-07 Quarterly Result Announcement NA -2.41%
2025-08-08 2025-08-08 Quarterly Result Announcement NA 1.04%
2025-08-08 2025-08-08 Annual General Meeting NA 3.91%
2025-05-26 2025-05-26 Quarterly Result Announcement NA 17.74%
2025-01-29 2025-01-29 Quarterly Result Announcement NA -4.56%
2024-10-29 2024-10-29 Quarterly Result Announcement NA -4.57%
2024-08-06 2024-08-06 Annual General Meeting NA 25.61%
2022-03-30 2022-04-01 Rights 1:5 -2.95%

Makers Laboratories Competitors Screener - Peer Stocks Comparison

Screen MAKERSL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 432,120 36.04 61,674 12.69% 11,565 36.68
Divis Laboratories 245,532 84.24 11,067 13.95% 2,568 51.70
Torrent Pharmaceuticals 181,333 84.71 13,886 20.34% 2,138 41.12
Zydus Life Science 114,284 25.27 27,658 17.64% 5,026 47.64
Cipla 108,576 32.50 29,045 2.24% 3,870 34.78
Laurus Labs 107,198 98.20 6,868 22.01% 890 58.70
Mankind Pharma 104,707 50.04 14,636 14.85% 1,938 61.75
Dr Reddys Laboratories 100,679 32.41 35,059 3.90% 4,158 53.84
Aurobindo Pharma 96,479 25.84 34,145 5.56% 3,503 50.30
Lupin 92,885 16.82 29,039 26.75% 5,356 31.59

Makers Laboratories Company Announcements - News & Reports Screener

Screen MAKERSL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 22, 2026.

The next most recent announcements are dated September 17, 2026 and September 10, 2026.

Date Update Actions
2026-09-22 Closure of Trading Window -
2026-09-17 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-10 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot -
2026-09-01 Announcement under Regulation 30 (LODR)-Credit Rating -
2026-08-10 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-07 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-08-07 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-07 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-07 Standalone And Consolidated Financial Results For Q1FY27 -
2026-08-07 Board Meeting Outcome for Outcome Of Board Meeting -
2026-07-23 Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 1St Quarter Ended June 30 2026 -
2026-07-13 Intimation To Shareholders Regarding Weblink Of Annual Report -
2026-07-13 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-10 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-07-10 41St Annual General Meeting Of The Company To Be Held On Friday 7Th August 2026 At 12.30 P.M. Through Video Conference -
2026-07-10 Reg. 34 (1) Annual Report. -
2026-07-02 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-06-23 Closure of Trading Window -
2026-06-09 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-27 Announcement under Regulation 30 (LODR)-Newspaper Publication -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹177.40, within a 52-week range of ₹152.59 to ₹220.86. The P/E ratio is 9.80 and the P/B ratio is 1.50, with earnings per unit of ₹3.99. Market capitalisation stands at ₹108.27 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 7, 2026. This page covers 6 balance sheet periods, 15 income statement periods, 6 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.